Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GliSODin Skin Nutrients is a nutricosmetic company that specializes in oral supplements designed to enhance skin health and complement aesthetic procedures. The company's products are built around the patented GliSODin technology, which is the first orally stable form of Superoxide Dismutase (SOD), a powerful antioxidant enzyme derived from cantaloupe melon. By combining SOD with a wheat protein called gliadin, the technology ensures the enzyme survives the digestive process to boost the body's natural antioxidant defenses. Their product line includes formulas for anti-aging, skin brightening, and pre- and post-surgical recovery, primarily distributed through dermatologists and plastic surgeons. The brand is managed by Coradin and utilizes research from the French laboratory Isocell.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GliSODin Skin Nutrients.